Tumour induction by ethylnitrosourea in the central nervous system;Inducción de tumores en el sistema nervioso central mediante etilnitrosourea

Revista de Neurologia

Volumn 43, Issue 12, 2006, Pages 733-738

  Bulnes Sesma, S ^a   Ullibarri Ortiz De Zarate N ^a   Lafuente Sanchez J V ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Brain tumour; Ethylnitrosourea; Glioma; MPNST; Neurooncology; Schwannoma

Indexed keywords

ALKYLATING AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ETHYLNITROSOUREA; PROTEIN P53; RAS PROTEIN; CARCINOGEN; TUMOR PROTEIN;

ASTROCYTOMA; BRAIN TUMOR; CANCER MODEL; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICAL CARCINOGENESIS; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; GLIA CELL; GLIOMA; MALIGNANT NEURILEMOMA; MIXED TUMOR; MUTAGENICITY; NEUROEPITHELIUM; NONHUMAN; OLIGODENDROGLIOMA; ONCOGENE; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SPRAGUE DAWLEY RAT; TRANSPLACENTAL CARCINOGENESIS; ANIMAL; ANIMAL MODEL; CHEMICALLY INDUCED DISORDER; DNA DAMAGE; DRUG EFFECT; EPENDYMOMA; EXPERIMENTAL NEOPLASM; FEMALE; MALE; MUTAGENESIS; NEURILEMOMA; PATHOLOGY; RAT;

ALKYLATING AGENTS; ANIMALS; ASTROCYTOMA; CARCINOGENS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA DAMAGE; EPENDYMOMA; ETHYLNITROSOUREA; FEMALE; GLIOMA; MALE; MODELS, ANIMAL; MUTAGENESIS; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NEURILEMMOMA; OLIGODENDROGLIOMA; ONCOGENES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 35348900301     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4312.2006174     Document Type: Review

References (53)

1. Bigner DD, Odom GL, Mahaley MS, Day ED. Brain tumors induced in dogs by the Schmidt-Ruppin strain of Rous sarcoma virus. Neuropathological and immunological observations. J Neuropathol Exp Neurol 1969; 28: 648-80.
2. Schold SC, Friedman HS. Human brain tumor xenografts. Prog Exp Tumor Res 1984; 28: 18-31.
3. Wilkins RH, Odom GL. Attempted induction of gliomas utilizing simian virus 40. Arch Neurol 1965; 13: 149-54.
4. Zurita-Castillo M, Vaquero-Crespo J. Neurocarcinogénesis. In Arraez MA, Acha T, Benavides M, eds. Tumores del SNC en el adulto y en la infancia. Madrid: Nova Sidonia Oncología y Hematología; 2003. p. 43-53.
5. Copeland DD, Talley FA, Bigner DD. The fine structure of intracranial neoplasms induced by the inoculation of avian sarcoma virus in neonatal and adult rats. Am J Pathol 1976; 83: 149-76.
6. Conde B, Sinués E, Gascón A, Alcalá A, Lorenzo H, Ruidíaz M. A new breast cancer cell line of epithelial origin is tumorigenic in athymic mice. Anticancer Res 1998; 18: 1751-5.
7. Ozawa T, Wang J, Hu LJ, Lamborn KR, Bollen AW, Deen DF. Characterization of human glioblastoma xenograft growth in athymic mice. In Vivo 1998; 12: 369-74.
8. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 1998; 36: 91-102.
9. Weizsaecker M, Deen DF, Rosenblum ML, Hoshino T, Gutin PH, Barker M. The 9L rat brain tumor: description and application of an animal model. J Neurol 1981; 224: 183-92.
10. Benda P, Someda K, Messer J, Sweet WH. Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg 1971; 34: 310-23.
11. Schmidek HH, Nielsen SL, Schiller AL, Messer J. Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg 1971; 34: 335-40.
12. Ko L, Koestner A, Wechsler W. Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol (Berl) 1980; 51: 23-31.
13. Kruse CA, Molleston MC, Parks EP, Schiltz PM, Kleinschmidt-DeMasters BK, Hickey WF. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol 1994; 22: 191-200.
14. Mennel HD, Kosse N, Heverhagen JT, Alfke H. Primary and transplanted ENU induced rat tumors in neurooncology. Exp Toxicol Pathol 2004; 56: 25-35.
15. Martínez A, Merchán J, Sala ML, Renedo G, Fernández-Pascual J, Bullón A. Carcinogénesis y nitrosamidas. Revista Española de Patología 1974; 7: 225-30.
16. Papathanasiou P, Goodnow CC. Connecting mammalian genome with phenome by ENU mouse mutagenesis: gene combinations specifying the immune system. Annu Rev Genet 2005; 39: 241-62.
17. Koestner A. Characterization of N-nitrosourea-induced tumors of the nervous system; their prospective value for studies of neurocarcinogenesis and brain tumor therapy. Toxicol Pathol 1990; 18: 186-92.
18. Katayama K, Ueno M, Yamauchi H, Nakayama H, Doi K. Microarray analysis of genes in fetal central nervous system after ethylnitrosourea administration. Birth Defects Res B Dev Reprod Toxicol 2005; 74: 255-60.
19. Druckrey H, Ivankovic S, Preussmann R. Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 1966; 210: 1378-9.
20. Lantos PL. Development of nitrosourea-induced brain tumours -with a special note on changes occurring during latency. Food Chem Toxicol 1986; 24: 121-7.
21. Nishio S, Ohta M, Abe M, Kitamura K. Microvascular abnormalities in ethylnitrosourea (ENU)-induced rat brain tumors: structural basis for altered blood-brain barrier function. Acta Neuropathol (Berl) 1983; 59: 1-10.
22. Jang T, Litofsky NS, Smith TW, Ross AH, Recht LD. Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis. Neurobiol Dis 2004; 15: 544-52.
23. Beniashvili DS, Benjamin S, Baturin DA, Anisimov VN. Effect of light/ dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats. Cancer Lett 2001; 163: 51-7.
24. Slikker W III, Mei N, Chen T. N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol Sci 2004; 81: 112-20.
25. Jones EL, Searle CE, Smith WT. Tumours of the nervous system induced in rats by the neonatal administration of N-ethyl-N-nitrosourea. J Pathol 1973; 109: 123-39.
26. Zook BC, Simmens SJ. Neurogenic tumors in rats induced by ethylnitrosourea. Exp Toxicol Pathol 2005; 57: 7-14.
27. Kish PE, Blaivas M, Strawderman M, Muraszko KM, Ross DA, Ross BD, et al. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J Neurooncol 2001; 53: 243-57.
28. Koutcher JA, Hu X, Xu S, Gade TP, Leeds N, Zhou XJ, et al. MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials. Neoplasia 2002; 4: 480-5.
29. Machein MR, Knedla A, Knoth R, Wagner S, Neuschl E, Plate KH. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol 2004; 165: 1557-70.
30. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003; 49: 848-55.
31. Ke LD, Shi YX, Im SA, Chen X, Yung WK. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Clin Cancer Res 2000; 6: 2562-72.
32. Vince GH, Bendszus M, Schweitzer T, Goldbrunner RH, Hildebrandt S, Tilgner J, et al. Spontaneous regression of experimental gliomas -an immunohistochemical and MRI study of the C6 glioma spheroid implantation model. Exp Neurol 2004; 190: 478-85.
33. Roberts TP, Chuang N, Roberts HC. Neuroimaging: do we really need new contrast agents for MRI? Eur J Radiol 2000; 34: 166-78.
34. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21: 891-9.
35. Cox DJ PG, Lantos PL. The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol 1976; 57: 419-30.
36. Burger PC, Shibata T, Aguzzi A, Kleihues P. Selective induction by N-nitrosoethylurea of oligodendrogliomas in fetal forebrain transplants. Cancer Res 1988; 48: 2871-5.
37. Vaquero J, Oya S, Coca S, Zurita M. Experimental induction of primitive neuro-ectodermal tumours in rats: a re-appraisement of the ENU-model of neurocarcinogenesis. Acta Neurochir (Wien) 1994; 131: 294-301.
38. Kroh H. Periphery of ethylnitrosourea-induced spinal gliomas in rats with special reference to the vascular structure. Acta Neuropathol (Berl) 1987; 73: 92-8.
39. Yoshimura F, Kaidoh T, Inokuchi T, Shigemori M. Changes in VEGF expression and in the vasculature during the growth of early-stage ethylnitrosourea-induced malignant astrocytomas in rats. Virchows Arch 1998; 433: 457-63.
40. Zook BC, Simmens SJ, Jones RV. Evaluation of ENU-induced gliomas in rats: nomenclature, immunochemistry, and malignancy. Toxicol Pathol 2000; 28: 193-201.
41. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000; 88: 2887.
42. Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular biology. Surg Neurol 2002; 58: 111-7.
43. Cavenee WK. High-grade gliomas with chromosome 1p loss. J Neurosurg 2000; 92: 1080-1.
44. Eckert KA, Hile SE, Vargo PL. Development and use of an in vitro HSV-tk forward mutation assay to study eukaryotic DNA polymerase processing of DNA alkyl lesions. Nucleic Acids Res 1997; 25: 1450-7.
45. Ceccotti S, Dogliotti E, Gannon J, Karran P, Bignami M. O6-methylguanine in DNA inhibits replication in vitro by human cell extracts. Biochemistry 1993; 32: 13664-72.
46. Katayama K, Ishigami N, Suzuki M, Ohtsuka R, Kiatipattanasakul W, Nakayama H, et al. Teratologic studies on rat perinates and offspring from dams treated with ethylnitrosourea (ENU). Exp Anim 2000; 49: 181-7.
47. Katayama K, Ueno M, Yamauchi H, Nakayama H, Doi K. Ethylnitrosourea- induced apoptosis in primordial germ cells of the rat fetus. Exp Toxicol Pathol 2002; 54: 193-6.
48. Hallas BH, Das GD. N-ethyl-N-nitrosourea-induced teratogenesis of brain in the rat. A cellular and cytoarchitectural analysis of the neocortex. J Neurol Sci 1978; 39: 111-22.
49. Perantoni AO, Rice JM, Reed CD, Watatani M, Wenk ML. Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc Natl Acad Sci USA 1987; 84: 6317-21.
50. Engelbergs J, Thomale J, Rajewsky MF. Role of DNA repair in carcinogen-induced ras mutation. Mutat Res 2000; 450: 139-53.
51. Leonard JR, D'Sa C, Klocke BJ, Roth KA. Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure. Oncogene 2001; 20: 8281-6.
52. Katayama K, Ueno M, Yamauchi H, Nagata T, Nakayama H, Doi K. Ethylnitrosourea induces neural progenitor cell apoptosis after S-phase accumulation in a p53-dependent manner. Neurobiol Dis 2005; 18: 218-25.
53. Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, Faraoni P, et al. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 2001; 61: 8803-10.